[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350620-105":59,"doc-detail-350620-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","il20rb-as-a-potential-biomarker-for-prognosis-in-clear-cell-renal-cell-carcinoma","IL20RB as a potential biomarker for prognosis in clear cell renal cell carcinoma","","Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer subtype and is associated with the worst prognosis. Complex histone deacetylase (HDAC) alterations contribute to tumor progression and patient outcomes, motivating investigation of HDAC-related molecular patterns in ccRCC. The study identifies HDAC-based subtypes via consensus clustering, performs differential expression, pathway enrichment, drug-sensitivity evaluation, and builds a validated 8-gene prognostic model. IL20RB emerges as a dependable prognostic factor, with pan-cancer links to poor survival and metastasis pathway activation, and elevated expression across ccRCC stages.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/il20rb-as-a-potential-biomarker-for-prognosis-in-clear-cell-renal-cell-carcinoma/350620/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/il20rb-as-a-potential-biomarker-for-prognosis-in-clear-cell-renal-cell-carcinoma/350620.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study on ccRCC prognosis?","Question",{"text":112,"@type":113},"The study investigates whether IL20RB and HDAC-based gene expression patterns can serve as prognostic biomarkers in clear cell renal cell carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were ccRCC disease subtypes defined in this research?",{"text":117,"@type":113},"Renal cancer was stratified into distinct subtypes using consensus clustering based on HDAC family gene expression profiles.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports IL20RB as a prognostic factor?",{"text":121,"@type":113},"Survival analysis shows IL20RB is a dependable prognostic factor in ccRCC, and its expression is significantly up-regulated in tumor tissues across stages; pan-cancer analysis also links IL20RB to poor prognosis and metastasis pathway activation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350620,1790168041,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Yuehua et al. BMC Cancer (2026) 26:862 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15755-3](https://doi.org/10.1186/s12885-026-15755-3)  \nRESEARCH Open Access  \nIL20RB as a potential biomarker for prognosis in clear cell renal cell carcinoma  \nLi Yuehua1, Xingyou Dong3, Li Guiqiang2, Ren Feiqiang2, Xu Bin2, Tan Wei2, Wang Jie2 and Guo Yu2*  \nAbstract  \nBackground Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinomas and is known for having the worst prognosis. It features a complex array of histone deacetylases (HDACs), which play varied roles in tumor progression and patient outcomes. Exploring the role and significance of HDACs in ccRCC can provide effective prognosis and treatment methods for ccRCC.  \nMethods We investigated the expression patterns of HDAC family genes in renal cancer and stratified the disease into distinct subtypes based on their expression profiles using consensus clustering. For each subtype, we conducted differential expression analysis, pathway enrichment analysis, and drug sensitivity evaluation. We then developed and validated a prognostic model utilizing genes associated with the HDAC-based subtypes across multiple independent cohorts. Finally, we collected clinical ccRCC samples and validated the expression of key genes, including IL20RB, using real-time quantitative PCR.  \nResults We identified three clusters linked to distinct HDAC expression patterns that demonstrate varied prognosis and drug sensitivities in ccRCC. Multi-omic analysis revealed distinct mutation and CNV profiles among these clusters, highlighting unique molecular characteristics. Additionally, an 8-gene model risk score, derived from HDAC expression patterns, has proven reliable as a prognostic marker in both training and validation cohorts for ccRCC. Survival analysis also showed that IL20RB is a dependable prognostic factor for ccRCC. Moreover, a pan-cancer analysis suggested that IL20RB is associated with poor prognosis and the activation of metastasis pathways in various types of cancer. Then, compared with tumor surrounding normal tissues, IL20RB expression was significantly up-regulated in in ccRCC tissues at all stages.  \nConclusion Our study delineates the role of HDACs in ccRCC, shedding light on their influence on tumor heterogeneity, immune modulation, drug response, and molecular profiles. Notably, IL20RB is identified not only asa promising therapeutic target but also as a prognostic indicator, thereby advancing the development of targeted therapies and precision medicine for this disease.  \nKeywords Clear cell renal cell carcinoma, Histone deacetylase, Consensus clustering, Prognostic signature, IL20RB  \n*Correspondence: Guo Yu [targeting1234@163.com](targeting1234@163.com)  \n1Department of Urology, University-Town Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of China 2Department of Urology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400000, People’s Republic of China  \n3Department of Urology, Chongqing Shapingba Hospital, School of Medicine, Chongqing University, Chongqing 400030, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regula","cbCaieiBirYz4GAH","https://ap.wps.com/l/cbCaieiBirYz4GAH","pdf",8253401,18,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of the study on ccRCC prognosis?\",\"answer\":\"The study investigates whether IL20RB and HDAC-based gene expression patterns can serve as prognostic biomarkers in clear cell renal cell carcinoma.\"},{\"question\":\"How were ccRCC disease subtypes defined in this research?\",\"answer\":\"Renal cancer was stratified into distinct subtypes using consensus clustering based on HDAC family gene expression profiles.\"},{\"question\":\"What evidence supports IL20RB as a prognostic factor?\",\"answer\":\"Survival analysis shows IL20RB is a dependable prognostic factor in ccRCC, and its expression is significantly up-regulated in tumor tissues across stages; pan-cancer analysis also links IL20RB to poor prognosis and metastasis pathway activation.\"}]","IL20RB as a potential biomarker for prognosis in clear cell renal cell carcinoma | PDF",1790089957,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d32fed3c7ae9579942e21b69f87bd7f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e10a80ec28270c9193f4edfd01ab0466.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57b4b5221e0000f341319e110a5b09de.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6d79e48ea3c4e2e05885d466742daae.webp",980,1306]